| Authors: |
Titulaer J; Section of Neuropsychopharmacology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.; Section of Neuropharmacology Addiction and Behavior, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., Björkholm C; Section of Neuropsychopharmacology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Feltmann K; Section of Neuropsychopharmacology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Malmlöf T; Section of Neuropsychopharmacology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Mishra D; Section of Neuropsychopharmacology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Bengtsson Gonzales C; Section of Neuropsychopharmacology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Schilström B; Section of Neuropsychopharmacology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Konradsson-Geuken Å; Section of Neuropsychopharmacology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.; Section of Neuropharmacology Addiction and Behavior, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. |
